Financement
Organisateur: ABBOTT LABORATORIES S.A.
7 financements - 598 039€
2023
2021
2019
-
Follow Up Availapreg Study
euro 39 938,00
2017
2016
-
Prognostic Relevance of Clinical Pharmacological, And Structural Parameters In The Course of Patiens Included In a Registry of Acute Coronary Syndrome
euro 50 000,00
-
Analyses of The Major Facilitator Superfamily Domain Containing 2a Protein (Mfsd2a) In Placentas From The Nigo-Health Study
euro 11 313,00
2009
-
Investigación en el Área Cardiovascular
euro 150 000,00